Hematology and Cell Therapy

COVID-19 and Hematology

COVID-19 gives as complex medical manifestations, from flu-like signs and symptoms to a couple of organ failure and death. According to the prognosis and remedy protocol for novel coronavirus pneumonia posted through the National Health Commission of China, there are 4 severity tiers of COVID-19 primarily based totally at the medical manifestations: mild, moderate, intense, and essential disease. Severe, in particular essential, instances are normally complex through different organ dysfunctions, such as septic shock, coronary heart failure, and disseminated intravascular coagulation (DIC).

In medical practice, a few thrombotic headaches were mentioned, such as ischaemic limbs, strokes, and venous thromboembolism. Venous thromboembolism is not unusual place in sufferers with intense disease. Although numerous research mentioned that reduced platelet matter and improved D-dimer have been related to intense COVID-19 and excessive mortality, few research have systematically assessed haematological and coagulation parameters amongst sufferers with moderate, intense, and essential COVID-19

• Full blood count and biochemistry findings
• The emerging role of biomarkers procalcitonin, ferritin and C-reactive protein in the prognosis
• Coagulation complications
• Blood and hematopoietic stem cell donation